VLA 0.00% $1.75 viralytics limited

re: Ann: Update - Phase 2 Melanoma Clinical T... The news flow...

  1. 925 Posts.
    re: Ann: Update - Phase 2 Melanoma Clinical T... The news flow has been great in recent weeks, would be great to see it continue although they might run out of information at this rate!

    Will be intresting to see how the next five patients progress, my guess is 2 will make the extension study
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.